Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04750564 · ClinicalTrials.gov registry record · NA

BreEStim for Motor Recovery in Chronic Stroke With Severe Impairment (Pilot)

A NA study, sponsored by The University of Texas Health Science Center, Houston.

Recruiting
Registry status
NA
Development phase
4
Enrollment target

NCT04750564: Recruiting NA study, sponsored by The University of Texas Health Science Center, Houston.

NCT04750564 is a NA study that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04750564, a NA study, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.

RECRUITING
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

The overall goal is to investigate the effectiveness of a novel intervention - Breathing-controlled electrical stimulation (BreEStim) on finger flexor spasticity reduction and hand function improvement in chronic stroke with severe impairment.

Primary Outcome

MAS will be performed to check changes of finger flexor spasticity after one session of treatment. The Modified Ashworth scale (MAS) scoring is categorical and ranges from 0 to 4, as follows: 0: No increase in muscle tone 1. Slight increase in muscle tone, manifested by a catch and release or by minimal resistance at the end of the range of motion when the affected part(s) is moved in flexion or extension 1+: Slight increase in muscle tone, manifested by a catch, followed by minimal resistanc

Interventions

  • DEVICE BreEStim
  • DEVICE EStim

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2025-09-01
Est. Completion 2027-12-31
Phase NA

What NCT04750564 shows while recruiting

NCT04750564 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which BreEStim is the first listed.

NCT04750564 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04750564 about?

NCT04750564 is a clinical study titled "BreEStim for Motor Recovery in Chronic Stroke With Severe Impairment (Pilot)". The overall goal is to investigate the effectiveness of a novel intervention - Breathing-controlled electrical stimulation (BreEStim) on finger flexor spasticity reduction and hand function improvement in chronic stroke with severe impairment.

What is the current status of trial NCT04750564?

This trial is currently recruiting. It is a NA study. The enrollment target is 4 participants. The study started on 2025-09-01. Estimated completion is 2027-12-31.

What interventions are being tested in trial NCT04750564?

The interventions under investigation include: BreEStim (DEVICE), EStim (DEVICE).

Who is sponsoring clinical trial NCT04750564?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04750564's enrollment target sits among peer trials

4 1996th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04750564, the US trial registry maintained by the National Library of Medicine. NCT04750564 (small enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.